Skip to content

What Medication is Used for Drooping Eyes? An In-Depth Look at Upneeq

4 min read

According to clinical studies, the prescription eye drop Upneeq provides a temporary but noticeable lift to eyelids in as little as 5-15 minutes, making it the primary answer to the question, "What medication is used for drooping eyes?". This FDA-approved solution offers a non-surgical alternative for adults with acquired ptosis, a common condition where the upper eyelid droops.

Quick Summary

Upneeq (oxymetazoline hydrochloride ophthalmic solution) is an FDA-approved eye drop that temporarily lifts droopy eyelids (acquired ptosis) by stimulating a specific eyelid muscle. It is a non-invasive treatment option with effects lasting for several hours.

Key Points

  • Upneeq is the primary medication: Upneeq® (oxymetazoline hydrochloride ophthalmic solution) is the only FDA-approved prescription eye drop for acquired droopy eyelids (ptosis) in adults.

  • Stimulates a specific muscle: The medication works by stimulating the Müller's muscle in the upper eyelid, causing it to contract and lift the eyelid.

  • Provides rapid, temporary results: Effects can be seen in as little as 5-15 minutes and last for up to 8 hours.

  • Not for all types of ptosis: Upneeq is only for acquired ptosis and will not work for congenital ptosis or cases caused by nerve damage.

  • Not a substitute for surgery: While an excellent non-invasive alternative, Upneeq provides temporary results and is not a permanent fix like ptosis surgery.

  • Requires medical consultation: A healthcare professional must determine if Upneeq is appropriate for you, especially if you have heart conditions, glaucoma, or other medical issues.

In This Article

Understanding Drooping Eyelids: Acquired Ptosis

Droopy eyelids, medically known as ptosis or blepharoptosis, can be a nuisance for both cosmetic and functional reasons. For many adults, it’s not just about looking tired; it can also obstruct vision by covering the pupil, affecting daily activities like reading and driving. The condition can be either congenital (present at birth) or acquired, developing later in life. Acquired ptosis, the form that medication addresses, often results from the stretching and weakening of eyelid muscles over time, though it can also be triggered by factors such as long-term contact lens use, certain eye surgeries, or underlying medical conditions.

The Medical Solution: Upneeq

For adults with acquired ptosis, the most prominent answer to the question "What medication is used for drooping eyes?" is Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%. This prescription eye drop is the first and only FDA-approved medication designed specifically for this condition.

How Upneeq Works

Upneeq works by stimulating the Müller's muscle, a small, involuntary muscle in the upper eyelid. The active ingredient, oxymetazoline, is an alpha-adrenergic agonist that causes this muscle to contract, gently raising the upper eyelid. This temporary lift can significantly open the eye, improving both appearance and the superior visual field. Notably, the same core ingredient is found in some nasal decongestant sprays, where it acts similarly by constricting blood vessels.

How to Use and What to Expect

Upneeq is designed for simple, once-daily use, administered as one drop per eye. For contact lens wearers, it's advised to remove lenses before application and wait at least 15 minutes before reinserting them.

  • Rapid Results: Many patients notice an improvement in their eyelid position in as little as 5 to 15 minutes after application.
  • Peak Effectiveness: The maximum lift is typically observed around two hours after the drops are applied.
  • Temporary Effects: The effect of a single dose lasts for approximately 6 to 8 hours.

Potential Side Effects

While generally well-tolerated, Upneeq can cause side effects. In clinical trials, the most common reactions (experienced by 1-5% of patients) included eye inflammation, redness, dry eye, blurred vision, headache, and eye irritation. More severe but less common side effects can involve increased eye pressure, which could lead to angle-closure glaucoma in at-risk individuals. It's crucial to discuss your full medical history with your healthcare provider, especially if you have heart disease, uncontrolled high or low blood pressure, or are taking certain medications.

Upneeq vs. Other Treatment Options

For those considering treatment for acquired ptosis, options range from medication to surgery. The choice depends on the severity of the condition, desired outcome, and individual health factors. For many, Upneeq offers a convenient, non-invasive alternative to surgery.

Feature Upneeq (Oxymetazoline) Ptosis Surgery (Blepharoplasty)
Permanence Temporary (lasts ~6-8 hours) Permanent
Invasiveness Non-invasive eye drops Invasive surgical procedure
Onset of Results Fast (as little as 5-15 minutes) Post-recovery (days to weeks)
Recovery Time None Days to weeks (swelling, bruising)
Cost Regular ongoing cost (per vial) One-time surgical cost
Ideal for Mild-to-moderate ptosis, temporary fixes Severe ptosis, long-term correction

Other Non-Medication Alternatives

While not a medication in the same sense, other approaches exist for managing drooping eyes. Some patients with mild ptosis might use specialized glasses with a "ptosis crutch"—an attachment that physically holds the eyelid up. For ptosis resulting from BOTOX injections, which is typically temporary, Upneeq can be used in the interim to provide a lift. Other non-surgical cosmetic options, such as certain dermal fillers, can sometimes help create the illusion of a lift, but they do not address the underlying muscle issue.

The Role of the Healthcare Provider

Before starting any treatment, including Upneeq, it is essential to have a thorough eye examination by an eye care professional. A doctor can help determine the exact cause of your drooping eyes and confirm if you have acquired ptosis, as more serious underlying conditions such as Horner syndrome or myasthenia gravis can also cause similar symptoms. A proper diagnosis ensures you receive the most appropriate and effective treatment plan. The medication is not suitable for congenital ptosis or ptosis caused by nerve damage or other conditions.

Conclusion

For adults experiencing acquired drooping eyelids, Upneeq offers a fast-acting, non-invasive way to temporarily lift the eyelid and improve vision. Unlike permanent surgical options, it provides a daily solution that is convenient and requires no recovery time. However, it is not a cure and is not suitable for all forms of ptosis. Understanding the different treatment options, including the benefits and limitations of Upneeq versus surgery, is key to making an informed decision with a healthcare provider. The primary medication used for drooping eyes is a safe and effective option for many, but always consult with a specialist to ensure it is the right choice for your specific needs.

Learn more about acquired ptosis and the various treatment paths by speaking with an ophthalmologist or visiting a resource like the American Academy of Ophthalmology.

Frequently Asked Questions

The prescription eye drop for treating acquired drooping eyelids, or ptosis, is called Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%.

Many patients notice visible improvements in their eyelid position in as little as 5 to 15 minutes after applying the eye drops. The maximum lift usually occurs within two hours.

The eyelid-lifting effect of a single dose of Upneeq typically lasts for up to 8 hours.

Common side effects, occurring in 1-5% of patients, include eye redness, inflammation, dry eye, blurry vision, headache, and eye irritation. Serious side effects, like increased eye pressure, are possible and require immediate medical attention.

You should inform your doctor of any health conditions, as Upneeq may impact blood pressure. Use with caution is advised for patients with cardiovascular disease, uncontrolled high or low blood pressure, and untreated narrow-angle glaucoma.

Upneeq is a temporary, non-invasive solution ideal for mild-to-moderate ptosis, while surgery (blepharoplasty) provides a permanent, more dramatic result for severe cases.

No, Upneeq is only for acquired ptosis, which develops later in life. It is not an effective treatment for congenital ptosis, which is present at birth.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.